CDK7-IN-12 structure
|
Common Name | CDK7-IN-12 | ||
---|---|---|---|---|
CAS Number | 2750638-94-7 | Molecular Weight | 400.40 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C20H19F3N6 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of CDK7-IN-12CDK7-IN-12 is a potent inhibitor of CDK7. CDK7-IN-12 plays a key role in transcriptional regulation and cell cycle regulation. CDK7-IN-12 effectively inhibit malignant tumor proliferation in vitro and in vivo. CDK7-IN-12 has the potential for the research of cancer disease (extracted from patent WO2021249417A1, compound 43)[1]. |
Name | CDK7-IN-12 |
---|
Description | CDK7-IN-12 is a potent inhibitor of CDK7. CDK7-IN-12 plays a key role in transcriptional regulation and cell cycle regulation. CDK7-IN-12 effectively inhibit malignant tumor proliferation in vitro and in vivo. CDK7-IN-12 has the potential for the research of cancer disease (extracted from patent WO2021249417A1, compound 43)[1]. |
---|---|
Related Catalog | |
References |
[1]. Jing Wang, et al. Heterocyclic compounds and their derivatives. Patent WO2021249417A1. |
Molecular Formula | C20H19F3N6 |
---|---|
Molecular Weight | 400.40 |